Remove Manufacturing Remove Pharmaceutical manufacturing Remove Pharmaceutical research
article thumbnail

Optimising drug release of personalised 3D printed tablets

European Pharmaceutical Review

The excipient matrix material selected for the tablets was PVA, the authors stated, as they intended for the dissolution process to be completed in “a few hours instead of over 20 [hours]” In terms of design, the printed tablets were manufactured “with 100 percent infill density”. This paper is published in Pharmaceutical Research.

article thumbnail

Ensuring adequate sanitisation: disinfectant-resistant microbes in cleanrooms

European Pharmaceutical Review

Microbes developing resistance to disinfectants is a major emerging problem in pharmaceutical manufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health. Microbial resistance is one of the factors responsible for such failings.

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5%